Stay updated on Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.4%

- Check9 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision label v3.7.0 was added to the history and the previous revision label v3.6.6 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedAn entry in the study record history shows Revision: v3.6.6 replacing the previous v3.6.5, indicating a software revision applied to the page history.SummaryDifference0.1%

- Check79 days agoChange Detected- The page now displays Revision: v3.6.5, replacing Revision: v3.6.4 in the footer/version area. This indicates a routine platform update rather than a modification to the trial record.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.